These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 10982252

  • 21. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG.
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 25. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
    Filip S, Bláha M, Odrázka K, Mericka P, Vávrová J.
    J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.
    Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R, Serke S, Huhn D.
    Ann Hematol; 1995 Nov; 71(5):227-34. PubMed ID: 7492625
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L, André M, Guillaume T, Feyens AM, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M.
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [Abstract] [Full Text] [Related]

  • 37. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
    Petsche D, Hami L, Purdy M, Myers S, Hogan C, Messner H, Briddell R, Heimfeld S, Berenson R, Shpall E.
    Prog Clin Biol Res; 1994 Mar; 389():415-20. PubMed ID: 7535450
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. New insights into the regulation of human megakaryocytopoiesis.
    Hoffman R, Straneva J, Yang HH, Bruno E, Brandt J.
    Blood Cells; 1987 Mar; 13(1-2):75-86. PubMed ID: 3499196
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.